Increase in Hospital Footfall for Surgical Treatments Propels Surgical Robots Deployment

In 2021, the surgical robots industry contributes $6,281.1 million, and the number is expected to grow and reach $30,067.2 million, advancing at a rate of 19% from 2022 to 2030, attributed to the rising requirement for hip and knee replacement surgeries, and the growing technological advancements.

Moreover, the increase in the demand for surgical robots, ascribed to the growing number of robotic surgeries, and the increased focus of governments and private players on the rising healthcare expenditure, with surging product approvals propel the industry. For example, there are around 600 planned investments worth $32million in the healthcare sector in India, according to the Investment Grid 2021 of Invest India. Thus, it creates opportunities to expand the medical devices and equipment industry to rise, led by the proliferation of pathology and diagnostics centers, along with miniaturized diagnostics.

Medtronic Canada ULC received a Health Canada license for the equipment having the potential to transform the surgical procedures, known as Hugo robotic-assisted surgery system, widely used in the gynaecologic laparoscopic and urologic surgical procedures. It ensures early recovery with fewer complications.

Under the end user segment, hospitals hold the largest share of the surgical robots industry, ascribed to the extensive surgeries performed in these healthcare facilities worldwide. The rise in the prevalence of chronic diseases, leading to an increased number of surgeries propels hospitals, resulting in the expansion of the market.

The neurology category is expected to generate the highest sales, progressing at a rate of 21% in the near future, in the surgical robots market, attributed to the technological advancements in the brain surgeries performed by robots and the rise in the employment of surgical robots to facilitate treatment of tumors, and other conditions of the brain. In addition, the growing incidences of neurological disorders and surge in the requirement for minimally invasive techniques propel the industry.

For example, the University of California San Francisco created a method to treat depressive symptoms by utilizing the DBS technology. It includes the implantation of electrodes within the brain to provide electrical currents that modify brain activity.  Such automatic on-demand therapy mitigates the symptoms of patients and shows long-term effects.

In addition, university researchers have developed speech neuroprosthesis for paralyzed patients. It provides support to patients having partially damaged brain stems, posing a risk of whole-body paralysis. Moreover, this technology is also utilized for epilepsy patients, and it also decodes the commands given to vocal muscles in real-time into words.

Furthermore, the demand for surgical robots is projected to rise due to the growing use of surgical robots in the treatment of abdominal, ovarian, and prostate cancer, due to the rising emergence of advanced technologies for laparoscopic operations. In addition, APAC is expected to showcase the highest growth in the near future, advancing at the rate of 20.7%, attributed to the rise in demand for minimally invasive operations to facilitate early recovery. The penetration of multinational companies in the region propels the market.

Therefore, the growing prevalence of chronic diseases requiring surgical treatments boosts the demand for surgical robots to provide minimally invasive treatment and ensure early recovery.

Report this Page